| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_227d476db4d9180cb091c7316e07608f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ae0d4e4b5a64a9a532bffd8513ed029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3fc9711989b2c07e13453d9e6a734d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ba6ad1806e6af5644981431aa1f9972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44fbe5b02d661b2a28cfb2187a78afce |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14141 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2016-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dbcd35b05c26c0d3271aca489cdd02e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ebc0bcf4c81762f088c041c3f96516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c025cdafa0b6ac20bb85b49ee4d145bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519338bcfbad83b4d0eba777e6e2ad2b |
| publicationDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017060510-A1 |
| titleOfInvention |
Methods and pharmaceutical compositions for the treatment of alzheimer's disease |
| abstract |
The present invention relates to methods and pharmaceutical compositions for the treatment of Alzheimer's disease. In particular, the present invention relates to a method of treating Alzheimer's disease in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a recombinant adeno-associated viral (AAV) vector comprising a polynucleotide encoding for an interleukin 2 (IL-2) polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021044175-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023111560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-201912863-D0
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022189797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109999179-A |
| priorityDate |
2015-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |